What is the DMRA stock price prediction for next 2 weeks?

According to our price prediction algorithm,Damora Therapeutics, Inc. (DMRA) price will be around $34.14 in the next 2 weeks. This means it will increase by 21.93107142857144 from the last closing price. This prediction may vary from other time period filters for DMRA stock.

What can be the highest Possible price of DMRA stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, DMRA can achieve the highest price of $35.84 which is 27.995401796329666 higher than last closing price. This prediction may vary from other time period filters for DMRA stock.

What can be the lowest Possible price of DMRA stock in next 2 weeks?

As per the forecast and algorithmic analysis, DMRA stock price can be as low as $32.44 which is 15.84659424724304 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for DMRA stock.

Will DMRA stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that DMRA stock will gain21.93107142857144 in the next 2 weeks. This prediction may vary from other time period filters for DMRA stock.

What is DMRA stock last closing price?

Last closing price of DMRA stock was $28.00.

What is DMRA stock price prediction?

DMRA stock price prediction means predicting the future closing prices of DMRA stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of DMRA stock in a certain time period.

How we predict DMRA stock future prices?

If you are searching for DMRA stock forecast, analysis or price prediction, then you might be wondering what Damora Therapeutics, Inc. (DMRA) will do in the future. Our DMRA price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This DMRA price prediction will likely answer most of your questions.

How frequent we update DMRA stock predictions?

We are updating the forecasts for the DMRA stock on daily basis.

Is using ML forecasting for DMRA stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for DMRA stock same for all the time periods?

No, the prediction for DMRA stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Damora Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$28.0015.65%Since 2 Weeks

Predicted Price$34.1421.93%For 2 Weeks

Upper Predicted Price$35.8428%For 2 Weeks

Lower Predicted Price$32.4415.85%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of DMRA will rise by +21.93% over the next 2 Weeks and hit $34.14 by Monday, July 27, 2026. In that time frame, DMRA's share price is expected to range between $32.44 and $35.84.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jul 27, 2026	32.44	34.14	35.84
Jul 24, 2026	31.66	33.21	34.84
Jul 23, 2026	31.31	32.88	34.39
Jul 22, 2026	30.10	31.58	33.02
Jul 21, 2026	30.64	31.97	33.46
Jul 20, 2026	30.05	31.44	32.83
Jul 17, 2026	29.07	30.50	31.90
Jul 16, 2026	28.77	30.17	31.57
Jul 15, 2026	27.47	28.88	30.21
Jul 14, 2026	27.95	29.27	30.64

DMRA shares fell -1.86% in Monday, July 13, 2026's trading session, dropping from a previous close of $28.53 to move at $28.00. The stock demonstrated notable intraday movement (see DMRA's key stats for a full breakdown), fluctuating between $26.29 and $28.91, a +9.95% trading range. While recent weeks have seen some volatility, DMRA has managed to secure a +15.65% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 269.78K shares changing hands, 42.85K fewer than the previous session. This amounted to $7.55M in total market activity.

Will DMRA Continue Its Upward Trend?

According to analyst ratings and projections for DMRA, Damora Therapeutics, Inc. shares are anticipated to increase by +21.87%, potentially reaching $35.84 per share by July 27, 2026. Short-term technical indicators currently suggest a bullish sentiment for DMRA. However, the stock has recorded 17 negative trading days within the past 30 sessions. Based on the DMRA stock forecast, now is a good time to buy DMRA stock because its current trading price is -17.99% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on DMRA covering social and institutional perspectives.

DMRA Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into DMRA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 55.79% to 56.82%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.60%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.29%, maintains a neutral outlook for the long term. Insights into DMRA's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Damora Therapeutics Short-Term Forecasts

DMRA Forecast For Next 5 Days

Our algorithm anticipates Damora Therapeutics (DMRA) stock could hit $30.56 by Jul 20, 2026. This represents a +9.16% fall from today's price, following a - change over the past five days.

DMRA Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Damora Therapeutics, Inc. (DMRA) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $29.51, which would mean a +5.39% increase from the current price of $28.00. Projections for this period range from a high of $34.46 to a low of $24.44.

DMRA Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Damora Therapeutics's price over the next three months point to a rise. DMRA stock is expected to peak at $765.51 on Aug 12, 2026 before potentially dipping to $0.00 on Oct 13, 2026. On average, DMRA is likely to trade around $59.90 in the coming 90 days.

Damora Therapeutics Stock Forecast 2025

Based on our predictive models, Damora Therapeutics (DMRA) is expected to trade between $0.00 and $765.51 throughout 2026. This would result in an average price of $32.14, potentially offering investors a +14.79% return from current levels.

Damora Therapeutics, Inc. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Damora Therapeutics, Inc. (DMRA) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $24.29, settling at an average of $2.80. This could translate to a -90.00% loss.

August 2026

Based on current market signals, Damora Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $0.00 to $765.51, with a likely average price of $186.41. Investors could expect a potential return of +565.75%.

September 2026

Our predictive algorithms indicate Damora Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$0.00, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.

October 2026

Analyzing established trends, Damora Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $0.00, averaging around $0.00. This suggests a -100.00% loss from current levels.

November 2026

Market indicators suggest Damora Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.

December 2026

Forecasting for December 2026, models estimate that Damora Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.

January 2027

According to our latest forecast models, Damora Therapeutics, Inc. (DMRA) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $704.56, settling at an average of $176.73. This could translate to a +531.18% gain.

February 2027

Based on current market signals, Damora Therapeutics, Inc. is projected to trend february 2027. We forecast a trading range from $0.00 to $0.00, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.

March 2027

Our predictive algorithms indicate Damora Therapeutics, Inc. stock may see a shift in March 2027. The expected range spans $0.00–$0.00, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.

April 2027

Analyzing established trends, Damora Therapeutics, Inc. looks set to move in April 2027. Projections place the stock between $0.00 and $0.00, averaging around $0.00. This suggests a -100.00% loss from current levels.

May 2027

Market indicators suggest Damora Therapeutics, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.

June 2027

Forecasting for June 2027, models estimate that Damora Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $654.17, averaging $145.88. This signals a positive trajectory with potential returns around +421.00%.

July 2027

According to our latest forecast models, Damora Therapeutics, Inc. (DMRA) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.00. This could translate to a -100.00% loss.

DMRA's history of dividends and stock splits also plays a role in long-term investor confidence.